Publications by authors named "F Gomez-Gallego"

Objectives: The aim of the study is to describe the most common medical grounds for requesting or extending teleworking and to examine which requests are typically approved. This study also investigates whether there is a correlation with gender, age, or job location.

Methods: A prevalence study of 33,190 Spanish employees found that, last year, 106 teleworking requests were addressed exclusively for medical reasons.

View Article and Find Full Text PDF

Background: In 2017, 69 108 work-related traffic injuries with medical leave were documented, constituting 12% of all occupational injuries (OI) in Spain.

Aims: The aim of this study was to describe OI within a Spanish bank company during 2017.

Methods: A cross-sectional analysis was conducted using the company's mandatory OI records, presenting data in both absolute (n) and relative (%) frequencies.

View Article and Find Full Text PDF

The role of polymorphism rs9939609 of the FTO gene has been related with fat mass and cardiovascular risk in adults, but it remains unclear in children and adolescents. Hence, the main aim of this study was to determine the FTO polymorphism effects on body composition, cardiorespiratory fitness (CRF), physical activity (PA), inflammatory markers, and cardiovascular risk both in cross-sectional analysis and after two-years of follow-up in children and adolescents. A total of 2129 participants were included in this study.

View Article and Find Full Text PDF

The FTO rs9939609 gene, which presents three polymorphisms (AA, AT, and TT), has been associated with the development of obesity through an increased fat accumulation; however, the associations of the gene with other physiological mechanisms, such as appetite or fat oxidation, are still unclear. Therefore, this study aims to evaluate the influence of the FTO rs9939609 gene on different obesity-related factors in young adults. The FTO rs9939609 polymorphism was genotyped in 73 participants (28 women, 22.

View Article and Find Full Text PDF

Background: A protective hepatitis B virus (HBV) vaccine has been available for four decades. Universal HBV vaccination of infants is recommended by the WHO since the 1990s. Furthermore, HBV immunization is advised for all adults with high-risk behaviours and no seroprotection.

View Article and Find Full Text PDF